Status
Conditions
Treatments
About
The overall goal is to improve diagnosis and non-operative management of urinary incontinence in women.
Full description
In the study, patients will be screened in primary care offices for symptoms of urinary incontinence. Women with positive screening results will be asked if they are interested in participating in an implementation study where women will be assigned to one of the three following groups:
All participants will complete questionnaires throughout their enrollment and data will be collected from medical records. The study team will analyze the data at six months after the original appointment/study enrollment, assess adherence to therapy and how the therapy impacted the outcomes the team hopes to improve, such as improvement in symptoms. The study will be implemented over three subsequent time periods called Wave 1, Wave 2 and Wave 3 with primary care practices from two geographic regions being involved in each wave (6 regions total). Participants in Wave 1 will be followed for a total of 18 months, while participants in Wave 2 will be followed for a total of 12 months, and participants in Wave 3 will be followed for 6 months. Primary care providers at all participating practices will be offered educational opportunities related to urinary incontinence.
Enrollment
Sex
Ages
Volunteers
Inclusion criteria
Exclusion criteria
None
Primary purpose
Allocation
Interventional model
Masking
400 participants in 3 patient groups
Loading...
Central trial contact
Ellen Divoky; Elisar Khawam
Data sourced from clinicaltrials.gov
Clinical trials
Research sites
Resources
Legal